<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01783509</url>
  </required_header>
  <id_info>
    <org_study_id>LGMD Nat Hx</org_study_id>
    <nct_id>NCT01783509</nct_id>
  </id_info>
  <brief_title>Limb Girdle Muscular Dystrophy (LGMD) Natural History</brief_title>
  <official_title>Longitudinal Assessment and Genetic Understanding of Limb-Girdle Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atrium Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Muscular Dystrophy Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Atrium Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand more about limb-girdle muscular dystrophy.&#xD;
      Therefore, the investigators would like to track the following information collected once a&#xD;
      year from patients with GENETICALLY CONFIRMED LGMD: quality of life questionnaires, muscle&#xD;
      strength, motor function, routine examination, assessment of patient (or parent)&#xD;
      understanding of LGMD, and serum (blood) for growth factors, cytokines, and biomarkers (all&#xD;
      parts of your blood). By tracking this information, we hope to be able to understand more&#xD;
      about the diagnosis, progression and natural history of this disorder.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Comprehensive clinical evaluation of individuals with GENETICALLY CONFIRMED LGMD, according to the study protocol, in order to evaluate disease progression</measure>
    <time_frame>yearly up to 10 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">13</enrollment>
  <condition>Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)</condition>
  <arm_group>
    <arm_group_label>LGMD</arm_group_label>
    <description>Patients with GENETICALLY CONFIRMED limb girdle muscular dystrophy</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a diagnosis of GENETICALLY CONFIRMED LGMD&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  You have a GENETICALLY CONFIRMED diagnosis of Limb Girdle Muscular Dystrophy&#xD;
&#xD;
          -  You must be at least 6 years of age or older (if under 18 you will need Parental&#xD;
             consent)&#xD;
&#xD;
          -  You must be able to travel to the study site&#xD;
&#xD;
          -  You must be able to provide a DNA/Gene testing report that confirms a diagnosis of&#xD;
             LGMD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  You or your child do not have a diagnosis of LGMD&#xD;
&#xD;
          -  Your child is under age 6&#xD;
&#xD;
          -  You or your child are not able to travel to the study site&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ibrahim Binalsheikh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carolinas Medical Center - Pediatrics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Carolinas Medical Center - Pediatrics</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>January 18, 2013</study_first_submitted>
  <study_first_submitted_qc>February 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2013</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GENETICALLY CONFIRMED limb girdle muscular dystrophy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophies, Limb-Girdle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

